• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定中国人群中与胰腺癌风险相关的 mA 修饰基因的遗传变异。

Identification of genetic variants in mA modification genes associated with pancreatic cancer risk in the Chinese population.

机构信息

Department of Epidemiology and Biostatistics, Key Laboratory for Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.

出版信息

Arch Toxicol. 2021 Mar;95(3):1117-1128. doi: 10.1007/s00204-021-02978-5. Epub 2021 Jan 21.

DOI:10.1007/s00204-021-02978-5
PMID:33474615
Abstract

N6-Methyladenosine (mA) is the most prevalent modification of RNA in eukaryotes, and is associated with many cellular processes and even the development of cancers. We hypothesized that single-nucleotide polymorphisms (SNPs) in mA modification genes, including its "writers", "erasers" and "readers", might affect the mA functions and associate with the susceptibility to pancreatic ductal adenocarcinoma (PDAC). We first conducted a two-stage case-control study in Chinese population to interrogate all SNPs in 22 mA modification genes. In the discovery stage, a total of 2735 SNPs were genotyped in 980 patients and 1991 controls. Then, the promising SNP was replicated in another independent population consisting of 858 cases and 2084 controls. As a result, we found the rs7495 in 3'UTR of hnRNPC was significantly associated with increased risk of PDAC in both stages (combined odds ratio = 1.22, 95% confidence interval = 1.12-1.32, P = 2.39 × 10). To further reveal the biological function of rs7495 and hnRNPC, we performed a series of biochemical experiments. Luciferase reporter assays indicated that rs7495G allele promoted hnRNPC expression through disrupting a putative binding site for has-miR-183-3p. Cell viability assay demonstrated that knockdown of hnRNPC suppressed the proliferation of PDAC cells. RNA-seq analysis suggested that as an mA "reader", hnRNPC played an important role in RNA biological processes. In conclusion, our findings elucidated that rs7495G could confer higher risk of PDAC via promoting the expression of hnRNPC through a miRNA-mediated manner. These results provided a novel insight into the critical role of mA modification in tumorigenesis.

摘要

N6-甲基腺苷(m6A)是真核生物中最普遍的 RNA 修饰,与许多细胞过程有关,甚至与癌症的发生有关。我们假设 m6A 修饰基因中的单核苷酸多态性(SNP),包括其“书写器”、“擦除器”和“读取器”,可能会影响 m6A 的功能,并与胰腺导管腺癌(PDAC)的易感性相关。我们首先在中国人群中进行了一项两阶段病例对照研究,以研究 22 个 m6A 修饰基因中的所有 SNP。在发现阶段,在 980 名患者和 1991 名对照中总共对 2735 个 SNP 进行了基因分型。然后,在另一个由 858 名病例和 2084 名对照组成的独立人群中对有希望的 SNP 进行了复制。结果发现,hnRNPC 3'UTR 中的 rs7495 与两个阶段 PDAC 的风险增加显著相关(合并优势比=1.22,95%置信区间=1.12-1.32,P=2.39×10)。为了进一步揭示 rs7495 和 hnRNPC 的生物学功能,我们进行了一系列生化实验。荧光素酶报告基因实验表明,rs7495G 等位基因通过破坏 hnRNPC 的一个潜在结合位点来促进 hnRNPC 的表达。细胞活力测定表明,hnRNPC 的敲低抑制了 PDAC 细胞的增殖。RNA-seq 分析表明,作为 m6A“读取器”,hnRNPC 在 RNA 生物学过程中发挥重要作用。总之,我们的研究结果表明,rs7495G 通过 miRNA 介导的方式促进 hnRNPC 的表达,从而增加 PDAC 的发病风险。这些结果为 m6A 修饰在肿瘤发生中的关键作用提供了新的见解。

相似文献

1
Identification of genetic variants in mA modification genes associated with pancreatic cancer risk in the Chinese population.鉴定中国人群中与胰腺癌风险相关的 mA 修饰基因的遗传变异。
Arch Toxicol. 2021 Mar;95(3):1117-1128. doi: 10.1007/s00204-021-02978-5. Epub 2021 Jan 21.
2
HNRNPC impedes mA-dependent anti-metastatic alternative splicing events in pancreatic ductal adenocarcinoma.HNRNPC 抑制胰腺导管腺癌中 mA 依赖性抗转移的可变剪接事件。
Cancer Lett. 2021 Oct 10;518:196-206. doi: 10.1016/j.canlet.2021.07.016. Epub 2021 Jul 13.
3
hnRNPC Promotes Malignancy in Pancreatic Cancer through Stabilization of IQGAP3.hnRNPC 通过稳定 IQGAP3 促进胰腺癌的恶性转化。
Biomed Res Int. 2022 Mar 20;2022:6319685. doi: 10.1155/2022/6319685. eCollection 2022.
4
Genetic variants in N6-methyladenosine are associated with bladder cancer risk in the Chinese population.N6-甲基腺苷的基因变异与中国人群的膀胱癌风险相关。
Arch Toxicol. 2021 Jan;95(1):299-309. doi: 10.1007/s00204-020-02911-2. Epub 2020 Sep 22.
5
MiR-377 inhibits the proliferation of pancreatic cancer by targeting Pim-3.微小RNA-377通过靶向原癌基因激酶3抑制胰腺癌的增殖。
Tumour Biol. 2016 Nov;37(11):14813-14824. doi: 10.1007/s13277-016-5295-4. Epub 2016 Sep 16.
6
Evaluation of polymorphisms in microRNA-binding sites and pancreatic cancer risk in Chinese population.评估中国人群中 miRNA 结合位点多态性与胰腺癌风险的关系。
J Cell Mol Med. 2020 Feb;24(3):2252-2259. doi: 10.1111/jcmm.14906. Epub 2019 Dec 27.
7
Investigating the interference of single nucleotide polymorphisms with miRNA mediated gene regulation in pancreatic ductal adenocarcinoma: An in silico approach.探讨单核苷酸多态性对胰腺导管腺癌中 miRNA 介导的基因调控的干扰:一种计算方法。
Gene. 2022 Apr 20;819:146259. doi: 10.1016/j.gene.2022.146259. Epub 2022 Feb 1.
8
Evaluation of genetic variants in microRNA biosynthesis genes and risk of breast cancer in Chinese women.评估 miRNA 生物合成基因中的遗传变异与中国女性乳腺癌风险的关系。
Int J Cancer. 2013 Nov;133(9):2216-24. doi: 10.1002/ijc.28237. Epub 2013 Jul 11.
9
Single nucleotide polymorphism in the microRNA-199a binding site of HIF1A gene is associated with pancreatic ductal adenocarcinoma risk and worse clinical outcomes.缺氧诱导因子1α(HIF1A)基因微小RNA-199a结合位点的单核苷酸多态性与胰腺导管腺癌风险及较差的临床预后相关。
Oncotarget. 2016 Mar 22;7(12):13717-29. doi: 10.18632/oncotarget.7263.
10
miR-545 inhibited pancreatic ductal adenocarcinoma growth by targeting RIG-I.miR-545 通过靶向 RIG-I 抑制胰腺导管腺癌生长。
FEBS Lett. 2014 Nov 28;588(23):4375-81. doi: 10.1016/j.febslet.2014.10.004. Epub 2014 Oct 12.

引用本文的文献

1
Role of m6A RNA methylation regulators in pancreatic cancer: interactions and potential implications.m6A RNA甲基化调节剂在胰腺癌中的作用:相互作用及潜在影响
Cancer Cell Int. 2025 Aug 4;25(1):292. doi: 10.1186/s12935-025-03922-8.
2
Genetic variants of mA modification genes are associated with survival of HBV-related hepatocellular carcinoma.mA 修饰基因的遗传变异与 HBV 相关肝细胞癌的生存相关。
J Cell Mol Med. 2024 Aug;28(16):e18517. doi: 10.1111/jcmm.18517.
3
N6-methyladenosine-associated genetic variants in NECTIN2 and HPCAL1 are risk factors for abdominal aortic aneurysm.

本文引用的文献

1
Identification and Validation of a Biomarker Signature in Patients With Resectable Pancreatic Cancer via Genome-Wide Screening for Functional Genetic Variants.通过全基因组筛选功能性遗传变异鉴定和验证可切除胰腺癌患者的生物标志物特征。
JAMA Surg. 2019 Jun 1;154(6):e190484. doi: 10.1001/jamasurg.2019.0484. Epub 2019 Jun 19.
2
LBX2-AS1 is activated by ZEB1 and promotes the development of esophageal squamous cell carcinoma by interacting with HNRNPC to enhance the stability of ZEB1 and ZEB2 mRNAs.LBX2-AS1 被 ZEB1 激活,并通过与 HNRNPC 相互作用来增强 ZEB1 和 ZEB2 mRNAs 的稳定性,从而促进食管鳞状细胞癌的发展。
Biochem Biophys Res Commun. 2019 Apr 9;511(3):566-572. doi: 10.1016/j.bbrc.2019.02.079. Epub 2019 Feb 26.
3
NECTIN2和HPCAL1中与N6-甲基腺苷相关的基因变异是腹主动脉瘤的危险因素。
iScience. 2024 Mar 4;27(4):109419. doi: 10.1016/j.isci.2024.109419. eCollection 2024 Apr 19.
4
The therapeutic targets of N6-methyladenosine (m6A) modifications on tumor radioresistance.N6-甲基腺苷(m6A)修饰对肿瘤放射抗性的治疗靶点。
Discov Oncol. 2023 Jul 31;14(1):141. doi: 10.1007/s12672-023-00759-3.
5
Role of N‑methyladenosine in the pathogenesis, diagnosis and treatment of pancreatic cancer (Review).N6-甲基腺苷在胰腺癌发病机制、诊断和治疗中的作用(综述)。
Int J Oncol. 2023 Jan;62(1). doi: 10.3892/ijo.2022.5452. Epub 2022 Nov 11.
6
N6-methyladenosine-related single-nucleotide polymorphism analyses identify oncogene RNFT2 in bladder cancer.N6-甲基腺苷相关单核苷酸多态性分析鉴定出膀胱癌中的癌基因RNFT2。
Cancer Cell Int. 2022 Oct 5;22(1):301. doi: 10.1186/s12935-022-02701-z.
7
Association of N6-methyladenosine readers' genes variation and expression level with pulmonary tuberculosis.N6-甲基腺苷读者基因变异与表达水平与肺结核的关联。
Front Public Health. 2022 Aug 22;10:925303. doi: 10.3389/fpubh.2022.925303. eCollection 2022.
8
Research advances of N6-methyladenosine in diagnosis and therapy of pancreatic cancer.N6-甲基腺苷在胰腺癌诊断与治疗中的研究进展。
J Clin Lab Anal. 2022 Sep;36(9):e24611. doi: 10.1002/jcla.24611. Epub 2022 Jul 15.
9
Role of main RNA modifications in cancer: N-methyladenosine, 5-methylcytosine, and pseudouridine.主要 RNA 修饰在癌症中的作用:N6-甲基腺苷、5-甲基胞嘧啶和假尿嘧啶。
Signal Transduct Target Ther. 2022 Apr 28;7(1):142. doi: 10.1038/s41392-022-01003-0.
10
Construction and validation of a novel prognostic model for lung squamous cell cancer based on N6-methyladenosine-related genes.基于 N6-甲基腺苷相关基因构建和验证肺鳞癌新型预后模型
World J Surg Oncol. 2022 Feb 27;20(1):59. doi: 10.1186/s12957-022-02509-1.
A dynamic reversible RNA N -methyladenosine modification: current status and perspectives.动态可逆 RNA N -甲基腺苷修饰:现状与展望。
J Cell Physiol. 2019 Jun;234(6):7948-7956. doi: 10.1002/jcp.28014. Epub 2019 Jan 15.
4
A mitochondrial FUNDC1/HSC70 interaction organizes the proteostatic stress response at the risk of cell morbidity.线粒体 FUNDC1/HSC70 相互作用以增加细胞病变风险的方式组织了稳态应激反应。
EMBO J. 2019 Feb 1;38(3). doi: 10.15252/embj.201798786. Epub 2018 Dec 27.
5
Cross-talk among writers, readers, and erasers of mA regulates cancer growth and progression.作家、读者和 mA 橡皮擦之间的串扰调节癌症的生长和进展。
Sci Adv. 2018 Oct 3;4(10):eaar8263. doi: 10.1126/sciadv.aar8263. eCollection 2018 Oct.
6
The 3D Genome Browser: a web-based browser for visualizing 3D genome organization and long-range chromatin interactions.3D 基因组浏览器:一个用于可视化 3D 基因组组织和长距离染色质相互作用的基于网络的浏览器。
Genome Biol. 2018 Oct 4;19(1):151. doi: 10.1186/s13059-018-1519-9.
7
RNA modifications modulate gene expression during development.RNA 修饰在发育过程中调节基因表达。
Science. 2018 Sep 28;361(6409):1346-1349. doi: 10.1126/science.aau1646.
8
The dual role of N6-methyladenosine modification of RNAs is involved in human cancers.RNA 中 N6-甲基腺苷修饰的双重作用与人类癌症有关。
J Cell Mol Med. 2018 Oct;22(10):4630-4639. doi: 10.1111/jcmm.13804. Epub 2018 Jul 24.
9
ALKBH5 Inhibits Pancreatic Cancer Motility by Decreasing Long Non-Coding RNA KCNK15-AS1 Methylation.ALKBH5通过降低长链非编码RNA KCNK15-AS1甲基化抑制胰腺癌转移。
Cell Physiol Biochem. 2018;48(2):838-846. doi: 10.1159/000491915. Epub 2018 Jul 20.
10
FTO-Dependent N-Methyladenosine Regulates Cardiac Function During Remodeling and Repair.FTO 依赖性 N6-甲基腺苷调节重塑和修复过程中心脏功能。
Circulation. 2019 Jan 22;139(4):518-532. doi: 10.1161/CIRCULATIONAHA.118.033794.